Persistence Market Research Company
Customize Now Get FREE Sample

Human Immunodeficiency Virus Therapeutics Market Size, Share, and Growth Forecast 2026 - 2033

Human Immunodeficiency Virus Therapeutics Market by Drug Class (Nucleoside Reverse Transcriptase Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Inhibitors, Entry & Fusion Inhibitors), Therapy Type (Antiretroviral Therapy, Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis, Long-acting Injectable Therapies), Drug Type (Branded Drugs, Generic Drugs), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Analysis, 2026-2033

ID: PMRREP33904| 210 Pages | 6 Feb 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Human Immunodeficiency Virus Therapeutics Market Snapshot 2026 and 2033
    2. Market Opportunity Assessment, 2026-2033, US$ Bn
    3. Key Market Trends
    4. Industry Developments and Key Market Events
    5. Demand Side and Supply Side Analysis
    6. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definitions
    2. Market Dynamics
      1. Driver
      2. Restraint
      3. Opportunities
      4. Trends
    3. Macro-Economic Factors
      1. Global GDP Outlook
      2. Global Haelthcare Expenditure
    4. Forecast Factors – Relevance and Impact
    5. COVID-19 Impact Assessment
  3. Value Added Insights
    1. Value Chain analysis
    2. Key Market Players
    3. Drug Adoption Analysis
    4. Key Promotional Strategies by key players
    5. PESTLE Analysis
    6. Porter's Five Forces Analysis
    7. Regulatory and Technology Landscape
  4. Global Human Immunodeficiency Virus Therapeutics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Global Human Immunodeficiency Virus Therapeutics Market Outlook: Drug Class
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Drug Class, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
        1. NRTIs
        2. NNRTIs
        3. Protease Inhibitors
        4. Integrase Inhibitors
        5. Entry & Fusion Inhibitors
      4. Market Attractiveness Analysis: Drug Class
    3. Global Human Immunodeficiency Virus Therapeutics Market Outlook: Therapy Type
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Therapy Type, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Therapy Type, 2026-2033
        1. Antiretroviral Therapy (ART)
        2. Pre-Exposure Prophylaxis (PrEP)
        3. Post-Exposure Prophylaxis (PEP)
        4. Long-acting Injectable Therapies
      4. Market Attractiveness Analysis: Therapy Type
    4. Global Human Immunodeficiency Virus Therapeutics Market Outlook: Durg Type
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Durg Type, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Durg Type, 2026-2033
        1. Branded Drugs
        2. Generic Drugs
      4. Market Attractiveness Analysis: Durg Type
    5. Global Human Immunodeficiency Virus Therapeutics Market Outlook: Distribution Channel
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Distribution Channel, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
  5. Global Human Immunodeficiency Virus Therapeutics Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
    3. Current Market Size (US$ Bn) Forecast, by Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Human Immunodeficiency Virus Therapeutics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. U.S.
      2. Canada
    3. North America Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
      1. NRTIs
      2. NNRTIs
      3. Protease Inhibitors
      4. Integrase Inhibitors
      5. Entry & Fusion Inhibitors
    4. North America Market Size (US$ Bn) Forecast, by Therapy Type, 2026-2033
      1. Antiretroviral Therapy (ART)
      2. Pre-Exposure Prophylaxis (PrEP)
      3. Post-Exposure Prophylaxis (PEP)
      4. Long-acting Injectable Therapies
    5. North America Market Size (US$ Bn) Forecast, by Durg Type, 2026-2033
      1. Branded Drugs
      2. Generic Drugs
    6. North America Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  7. Europe Human Immunodeficiency Virus Therapeutics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Europe Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
      1. NRTIs
      2. NNRTIs
      3. Protease Inhibitors
      4. Integrase Inhibitors
      5. Entry & Fusion Inhibitors
    4. Europe Market Size (US$ Bn) Forecast, by Therapy Type, 2026-2033
      1. Antiretroviral Therapy (ART)
      2. Pre-Exposure Prophylaxis (PrEP)
      3. Post-Exposure Prophylaxis (PEP)
      4. Long-acting Injectable Therapies
    5. Europe Market Size (US$ Bn) Forecast, by Durg Type, 2026-2033
      1. Branded Drugs
      2. Generic Drugs
    6. Europe Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  8. East Asia Human Immunodeficiency Virus Therapeutics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    3. East Asia Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
      1. NRTIs
      2. NNRTIs
      3. Protease Inhibitors
      4. Integrase Inhibitors
      5. Entry & Fusion Inhibitors
    4. East Asia Market Size (US$ Bn) Forecast, by Therapy Type, 2026-2033
      1. Antiretroviral Therapy (ART)
      2. Pre-Exposure Prophylaxis (PrEP)
      3. Post-Exposure Prophylaxis (PEP)
      4. Long-acting Injectable Therapies
    5. East Asia Market Size (US$ Bn) Forecast, by Durg Type, 2026-2033
      1. Branded Drugs
      2. Generic Drugs
    6. East Asia Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  9. South Asia & Oceania Human Immunodeficiency Virus Therapeutics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of SAO
    3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
      1. NRTIs
      2. NNRTIs
      3. Protease Inhibitors
      4. Integrase Inhibitors
      5. Entry & Fusion Inhibitors
    4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Therapy Type, 2026-2033
      1. Antiretroviral Therapy (ART)
      2. Pre-Exposure Prophylaxis (PrEP)
      3. Post-Exposure Prophylaxis (PEP)
      4. Long-acting Injectable Therapies
    5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Durg Type, 2026-2033
      1. Branded Drugs
      2. Generic Drugs
    6. South Asia & Oceania Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  10. Latin America Human Immunodeficiency Virus Therapeutics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of LATAM
    3. Latin America Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
      1. NRTIs
      2. NNRTIs
      3. Protease Inhibitors
      4. Integrase Inhibitors
      5. Entry & Fusion Inhibitors
    4. Latin America Market Size (US$ Bn) Forecast, by Therapy Type, 2026-2033
      1. Antiretroviral Therapy (ART)
      2. Pre-Exposure Prophylaxis (PrEP)
      3. Post-Exposure Prophylaxis (PEP)
      4. Long-acting Injectable Therapies
    5. Latin America Market Size (US$ Bn) Forecast, by Durg Type, 2026-2033
      1. Branded Drugs
      2. Generic Drugs
    6. Latin America Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  11. Middle East & Africa Human Immunodeficiency Virus Therapeutics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. GCC Countries
      2. South Africa
      3. Northern Africa
      4. Rest of MEA
    3. Middle East & Africa Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
      1. NRTIs
      2. NNRTIs
      3. Protease Inhibitors
      4. Integrase Inhibitors
      5. Entry & Fusion Inhibitors
    4. Middle East & Africa Market Size (US$ Bn) Forecast, by Therapy Type, 2026-2033
      1. Antiretroviral Therapy (ART)
      2. Pre-Exposure Prophylaxis (PrEP)
      3. Post-Exposure Prophylaxis (PEP)
      4. Long-acting Injectable Therapies
    5. Middle East & Africa Market Size (US$ Bn) Forecast, by Durg Type, 2026-2033
      1. Branded Drugs
      2. Generic Drugs
    6. Middle East & Africa Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping
      2. Competition Dashboard
    3. Company Profiles
      1. Gilead Sciences, Inc.
        1. Company Overview
        2. Product Portfolio/Offerings
        3. Key Financials
        4. SWOT Analysis
        5. Company Strategy and Key Developments
      2. ViiV Healthcare
      3. Merck & Co., Inc.
      4. Johnson & Johnson (Janssen Pharmaceuticals)
      5. AbbVie Inc.
      6. Bristol-Myers Squibb Company
      7. Cipla Limited
      8. Teva Pharmaceutical Industries Ltd.
      9. Viatris Inc.
      10. Aurobindo Pharma Ltd.
      11. Hetero Drugs Limited
      12. Sun Pharmaceutical Industries Ltd.
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate